Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.

By MD Daniel H. S. Silverman, P. Small, Matthew Chang, B.-X. Lu, BSc Michelle A. Kung de Aburto, BSc Wei Chen, PhD Johannes Czernin, M. Rapoport, MD Pietro Pietrini, P. Md and 15 more. Journal of the American Medical Association (JAMA), 2001

927 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Physiology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/fb4679cf1cedde897480a325c5766905fe209037

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

In Physiology

In Psychiatry and Mental health

Citations in the corpus

Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. (2005, background): “…Killiany et al., 2000; van der Flier, van den Heuvel, Weverling-Rijnsburger, Bollen, et al., 2002), glucose metabolism (e.g., Arnáiz et al., 2001; Silverman et al., 2001), blood flow (e.g., Kogure et al., 2000; S. A. Small et al., 1999 ), amyloid deposits (Morris & Price, 2001; Yamaguchi et al.,…”
Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. (2013, background): “In addition, the studies also provide definitive evidence that FDG-PET has the capacity of high specificity in differentiating AD from other types of dementia (Albin et al., 1996; Silverman et al., 2001).”
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline (2007, background): “normal) PET strongly favours a normal outcome at follow up [94].”
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET (2002, background): “Silverman et al., 2001).”
Random forest-based similarity measures for multi-modal classification of Alzheimer's disease (2013, neutral): “Reduced metabolism in AD patients is predictive of their cognitive decline and histopathological diagnosis (Hoffman et al., 2000; Silverman et al., 2001), and in MCI patients can predict their progression to AD (Anchisi et al., 2005).”
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. (2018, background): “Consistent with atrophy on structural MRI, FDG-PET studies show hypometabolism within the mesial temporal and parietal areas (Hoffman et al. 2000; Silverman et al. 2001).”
Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease (2012, background): “One of the major functional defects in AD is a massive decrease in neuronal activity (2, 3).”